Document Detail

Stereotactic radiosurgery for the treatment of primary sarcomas and sarcoma metastases of the spine.
MedLine Citation:
PMID:  19165074     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Spinal sarcomas pose unique treatment dilemmas because of the difficulty of achieving adequate surgical margins and/or delivering curative radiation doses (65 Gy) in close proximity to the spinal cord. This study used hypofractionated stereotactic radiosurgery (SRS) to deliver higher biologically effective doses to treat primary spinal sarcomas and spinal sarcoma metastases. METHODS: Twenty-four patients with spinal or paraspinal sarcomas entered an Institutional Review Board-approved registry trial to evaluate SRS efficacy. They were assessed at regular intervals for pain control, disease progression, and complications for a minimum of 12 months or until death. RESULTS: The median treatment dose for the spinal sarcoma lesions was 30 Gy at the 80% isodose in 3 fractions, with some variation based on tumor size, shape, and dose to adjacent critical structures. Seven patients were treated definitively; all had excellent pain relief and are alive with a mean follow-up period of 33 months. Two patients had complete tumor regression, 3 had partial regression, and 2 experienced recurrences and have been re-treated. Seven patients underwent resection and adjuvant SRS. One of 3 patients treated preoperatively had complete tumor regression, and none of the 4 patients treated postoperatively had a local recurrence with a mean follow-up period of 43.5 months. All 10 patients with sarcoma metastases to the spine (16 lesions) died, with a mean survival of 11.1 months from first spinal metastasis treatment. Complete pain relief was achieved in 8 patients, partial relief in 7 patients, and none in 1 patient. No patient developed radiation myelitis. CONCLUSION: These preliminary results suggest that SRS may have a role in the definitive treatment of patients with primary spinal sarcomas who are deemed unresectable and as adjuvant treatment in those undergoing surgery and for palliation of sarcoma metastases.
Alan M Levine; Cardella Coleman; Sylvia Horasek
Related Documents :
15201364 - Effects of surgery on the sensory deficits of syringomyelia and predictors of outcome: ...
1440204 - Multimodality treatment of deep periventricular cerebral arteriovenous malformations.
15696264 - Gamma knife radiosurgery in skull base meningiomas: a possible relationship between som...
11031414 - Endovascular treatment of acute and subacute hemorrhage in the head and neck.
9366304 - Blindness in children with neuroblastoma.
20629074 - Submandibular salivary gland transfer for the prevention of radiation-induced xerostomi...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Neurosurgery     Volume:  64     ISSN:  1524-4040     ISO Abbreviation:  Neurosurgery     Publication Date:  2009 Feb 
Date Detail:
Created Date:  2009-01-23     Completed Date:  2009-03-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802914     Medline TA:  Neurosurgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  A54-9     Citation Subset:  IM    
Department of Orthopedic Oncology, Alvin and Lois Lapidus Cancer Institute, Sinai Hospital of Baltimore, Baltimore, Maryland 21215, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Combined Modality Therapy
Dose Fractionation
Middle Aged
Orthopedic Procedures
Pain / surgery
Radiosurgery* / methods
Radiotherapy, Adjuvant / methods
Sarcoma / pathology,  secondary,  surgery*
Spinal Neoplasms / pathology,  secondary,  surgery*
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of chordomas with CyberKnife: georgetown university experience and treatment recommendatio...
Next Document:  CyberKnife stereotactic radiotherapy for spinal tumors: value of computed tomographic myelography in...